Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
Go back to Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.87 +0.03 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.84 | 52 Week High | $2.18 | |||
| Open | $12.09 | 52 Week Low | $0.30 | |||
| Day High | $12.18 | P/E | N/A | |||
| Day Low | $11.73 | EPS | $-3.32 | |||
| Volume | 255,241 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.87 +0.03 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.84 | 52 Week High | $2.18 | |||
| Open | $12.09 | 52 Week Low | $0.30 | |||
| Day High | $12.18 | P/E | N/A | |||
| Day Low | $11.73 | EPS | $-3.32 | |||
| Volume | 255,241 | |||||

